From Expression to Function: Challenges in Recombinant Protein Development and Functional Characterization

Abstract

Recombinant protein development requires not only successful expression and purification, but also the recovery of stable and functionally active proteins. In this study, five recombinant proteins were used as case examples to examine key challenges in early-stage recombinant protein production and functional characterization. These included three oat seed lipase 1 variants, OL522, OL118, and OL183, and two enamel-related proteins, amelotin and amelogenin-mid. All constructs were expressed in Escherichia coli BL21(DE3) using a pET11 expression system. Protein expression, extraction, solubility, purification, refolding, and preliminary functional behavior were evaluated mainly by SDS-PAGE, immobilized metal affinity chromatography, fluorescence-based lipase activity assays, and turbidity-based mineralization analysis.
The results showed that all five recombinant proteins were expressed and obtained after purification using their respective strategies. The three oat lipase variants showed enzymatic activity after refolding, although the activity was inconsistent and unstable. Amelotin showed calcium- and phosphate-dependent precipitation, indicating a possible mineralization-associated response.
Overall, the target recombinant proteins were successfully obtained, but reliable functional validation requires further investigation.

Popular Abstract

Proteins are invisible to the naked eye, but they can feel like tiny living things: each has its own personality. Some are easy to work with, while others are picky and need the right conditions before they can do their job. Their “personalities” come from their structures, and those structures determine what they are able to do. Some proteins act like tiny machines that speed up chemical reactions, while others help build hard tissues, such as tooth enamel. Today, proteins are used in many areas, from modern medicine to industrial production. This makes them highly valuable, but also challenging to develop.
Scientists can use bacteria as small factories to produce proteins by giving them the right genetic instructions. At first glance, this may sound simple: insert the gene, grow the bacteria, and collect the protein. In reality, the hardest part often begins after the protein has been made. This is because it is difficult to make sure that the protein keeps the right structure, remains stable, and actually does what it is supposed to do.
This project studied that challenge using five different recombinant proteins. Three of them were variants of an oat lipase, an enzyme related to fat breakdown. The other two were human enamel-related proteins, amelotin and part of amelogenin, which are connected to the formation of tooth enamel. Together, they provided two different examples of what researchers need to check before a newly produced protein can be considered useful.
All five proteins could be produced in E. coli, a bacterium often used as a small “protein factory”. However, the results showed that production alone does not prove success. A protein is not just a chain of building blocks. It must fold into the right structure, a little like origami: the paper is there, but if it is folded in the wrong way, it will not become the object you wanted.
This was especially clear for the oat lipase variants. These proteins needed to be unfolded and then carefully refolded before their activity could be tested. Some activity was observed, particularly for the shortest variant, OL183, and the results suggested that pH 7.5 was the most promising condition among those tested. However, the activity was not always reproducible. Sometimes a sample that looked normal on a protein gel did not show clear enzyme activity. This was an important lesson: a protein can appear to be present and intact, while still not working properly.
The enamel-related proteins behaved differently. They were easier to recover, and amelotin showed an interesting response when calcium and phosphate were added. These two ions are important building blocks of tooth mineral. In the experiment, visible changes and small deposits appeared only when amelotin was present together with both calcium and phosphate.

This suggests that amelotin may interact with mineral-forming components, although further tests are needed to confirm exactly what the deposits were.
The broader value of this work is not only in these individual proteins. It highlights a general problem in protein development: early results can be misleading if researchers only ask, “Did we make the protein?” A better question is, “Can we make it, keep it stable, and let it works?” This matters for biotechnology, medicine and biomaterials research, where time and resources can be wasted if unsuitable protein candidates are carried forward too early.
In the future, improved protein quantification, more standardized activity tests, and better structural analysis could make the results more reliable. For the oat lipase variants, this could help identify which parts of the protein are most important for activity. For amelotin, further analysis could show whether the observed deposits are true mineral-like material.
In short, this project shows that recombinant protein development is like teaching a tiny machine not only to exist, but to work. Producing the protein is the first step. Understanding whether it is stable, correctly folded, and functional is the real challenge.

• author: Bai, Yumei
• supervisor: Johan Svensson Bonde; Sofia Marmon; Miho Oda
• organization: Pure and Applied Biochemistry
• course: KBKM01 20261
• year: 2026
• type: H2 - Master's Degree (Two Years)
• subject: Technology and Engineering; Biology and Life Sciences
• keywords: recombinant protein expression, protein purification, refolding, oat lipase, enzymatic activity, amelotin, biomineralization, applied biochemistry
• language: English
• id: 9236655
• date added to LUP: 2026-06-17 13:56:28
• date last changed: 2026-06-17 13:56:28